OpenLegislation

Division 2.1 The entry assessment shall consist of assessing the likelihood that the BSE agent has either been introduced into the country or region via commodities potentially contaminated with a BSE agent, or is already present in the country or region.F1F2

United Kingdom

Original text. Later amendments are not shown.

The following risk factors shall be taken into account:

  1. (a)

    the presence or absence of the BSE agent in the country or region and, if the agent is present, its prevalence based on the outcome of surveillance activities;

  2. (b)

    the production of meat-and-bone meal or greaves from the BSE indigenous ruminant population;

  3. (c)

    imported meat-and-bone meal or greaves;

  4. (d)

    imported bovine and ovine and caprine animals;

  5. (e)

    imported animal feed and feed ingredients;

  6. (f)

    imported products of ruminant origin for human consumption, which may have contained tissues listed in point 1 of Annex V and may have been fed to bovine animals;

  7. (g)

    imported products of ruminant origin for in vivo use in bovine animals.

Annotations

Textual amendments

F1

Substituted by Commission Regulation (EC) No 722/2007 of 25 June 2007 amending Annexes II, V, VI, VIII, IX and XI to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).

F2

Substituted by Commission Regulation (EU) No 1148/2014 of 28 October 2014 amending Annexes II, VII, VIII, IX and X to Regulation (EC) No 999/2001 of the European Parliament and of the Council laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).

Notes on the whole EU Regulation

Textual amendments

F1

Inserted by Regulation (EC) No 1923/2006 of the European Parliament and of the Council of 18 December 2006 amending Regulation (EC) No 999/2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).